Myasthenia gravis market across 7MM set to grow at 5.3% CAGR between 2024 and 2034, forecasts…
Growth driven by rising diagnosed prevalence and launch of late-stage pipeline therapies, despite pressure from biosimilar…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Merck’s Enflonsia to gain competitive advantage in paediatric RSV prophylaxis market with lack of…
FDA-approved Enflonsia enters US paediatric RSV market as the only prophylactic not requiring weight-based dosing, posing new…
Lupin signs licensing deal with Sino Universal Pharmaceuticals to supply Tiotropium DPI in China
Under the agreement, Lupin will manufacture and hold marketing authorisation, while SUP will lead regulatory approvals for COPD…
Sun Pharma appoints Kirti Ganorkar as Managing Director, announces key managerial shifts
Dilip Shanghvi will continue as the Executive Chairman of the Board, while Richard Ascroft joins Sun Pharma as CEO – North…
Driving change: Digital innovation and the future of drug discovery in India
Dr Trupti Kad-Shinde, Senior member, Medical Research and content team, ImmersiveVision Technology and Dr Debashree Das,…
Role of nitric oxide in controlling genetic regulators to maintain cellular health
Prof Syamantak Majumder, Prof Sandeep Sundriyal, and Prof Shibasish Chowdhury, researchers at BITS Pilani, reveal how nitric oxide…
Small benefits, big impact: Understanding the value of novel drugs in metastatic cancer
Dr Jahnavi Pedireddy, Medical Oncology Trainee, Apollo Hospitals, Bengaluru; Dr Narendhar Gokulanathan, Medical Oncology Trainee,…
India needs to step up more as a strategic innovator in the global supply chain
In a free wheeling conversation, US-based Hari Kiran Chereddi, MD, HRV Global Life Sciences explains to Viveka Roychowdhury that…
Access to diabetes care for children and young people: Pharma companies’ current actions and…
A recently released report from Access to Medicine Foundation highlights that children and young people living in low-and…
Data cleaning and harmonisation: A catalyst for innovation
Messy data remains a persistent challenge in modern drug discovery. The complementary processes of data cleaning and data…
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData
GlobalData analysts highlight uncertainty around new FDA directives as pharma giants ramp up US-based manufacturing investments…
OneSource Specialty Pharma’s Bangalore facility maintains US FDA compliance with VAI classification
US FDA concludes inspection of OneSource’s flagship site with Voluntary Action Indicated status, confirming regulatory adherence…
Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India
Biscado enters India’s beta-blocker therapy space, addressing the growing burden of heart disease with clinically supported…
CII Telangana to host “Pillars of Protection”conference on pharma and chemical safety
Hyderabad to host industry-wide dialogue on safety, compliance, and risk management in pharma and chemical manufacturing on 25th…
Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli…
M&A and venture capital deals in the global healthcare sector declined from the 12-month average, with three transactions…
Lupin receives tentative US FDA approval for Oxcarbazepine ER tablets
Oxcarbazepine extended-release tablets to be manufactured at Lupin’s Nagpur facility for US market
Supriya Lifescience’s Saloni Wagh and Shivani Wagh named in 2025 Candere Hurun India Women Leaders…
Leadership of Saloni Wagh and Shivani Wagh recognised as Supriya Lifescience posts highest-ever revenue in FY25
PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis:…
As current IPF treatments face adoption and efficacy challenges, GlobalData highlights LYT-100’s potential to address unmet needs…
ASPA commissions 2nd edition of counterfeiting report ahead of World Anti-Counterfeiting Day
The ASPA–CRISIL 2025 report will assess counterfeiting risks across key sectors in India and offer data-driven insights for brand…
Renewables to account for over half of Brazil’s annual power generation in 2035, forecasts…
Government policies, market liberalisation, and project development expected to accelerate Brazil’s shift from hydropower…